Skip to main content
Have a personal or library account? Click to login
Synthesis and pharmacophore modeling of novel quinazolines bearing a biologically active sulfonamide moiety Cover

Synthesis and pharmacophore modeling of novel quinazolines bearing a biologically active sulfonamide moiety

Open Access
|Mar 2013

References

  1. 1. M.M. Ghorab, S. E. Barakat, H. M. Saker andM. M. Abd Rabo, Synthesis and antitumor activity of some novel quinazoline derivatives bearing the biologically active thione moiety,.(2006) 665-670; DOI: 10.1002/chin.200703141.
  2. 2. S. E. Barakat, M. M. Ghorab, H. M. Saker and M. M. Abd Rabo, Novel quinazolinone derivatives as possible antitumor agents,(2007) 65-77; DOI: 10.1080/ 10426500600867042.
  3. 3. M. M. Ghorab, S. M. Abdel-Gawad and M. S. A. El-Gaby, Synthesis and evaluation of some new fluorinated hydroquinazoline derivatives as antifungal agents,(2000) 249-255; DOI: 10.1016/S0014-827X(00)00029-X.
  4. 4. S. M. Abdel-Gawad, M. S. A. El-Gaby and M. M. Ghorab, Synthesis and antifungal activity of novel pyrano[2’,3’:4,5]thiazolo[2,3-]quinazolines, pyrido[2’,3’:4,5]thiazolo[2,3-]quinazolines and pyrazolo[2’,3’:4,5]thiazolo[2,3-]quinazolines,(2000) 287-292; DOI: 10.1016/S0014- -827X(00)00042-2.
  5. 5. M.M. Ghorab, S. G. Abdel-Hamide, M. S. A. El-gaby and S. M. El-Sayed, Synthesis and effect of some new [1,2,4]triazolo [4,3-a]quinazolin-5(4)-ones and related compounds on Ehrlich ascites carcinoma cells,(1999) 1-10.
  6. 6. M.M. Ghorab, S. G. Abdel-Hamide and S. M. El-Sayed, Novel quinazolone derivatives as antitumor agents,(1998) 57-68; DOI: 10.1080/10426509808029666.
  7. 7. S. Jantova, D. Hudecova, S. Stankova and L. Ruzekova, Antibacterial effect of substituted 4-quinazolylhydrazines and their arylhydrazones determined by a modified microdilution method,(1995) 611-614; DOI: 10.1007/BF02818517.
  8. 8. N. B. Patel, J. C. Patel and G. G. Barat, Synthesis and antimicrobial activity of 2-[2-(2,6-dichlorophenyl) amino]benzyl-3-(5-substituted phenyl-4,5-dihydro-1-pyrazol-3-yl-amino)-6,8-dibromoquinazolin-4(3H)ones,(2010) 173-182; DOI: 10.4103/0975-1483.63165.
  9. 9. V. Gupta, S. K. Kashaw, V. Jatav and P. Mishra, Synthesis and antimicrobial activity of some new 3-[5-(4-substituted) phenyl-1,3,4-oxadiazole-2yl]-2-styrylquinazoline-4(3H)-ones,.(2008) 205-211; DOI: 10.1007/s00044-007-9054-3.
  10. 10. P. Kumar, C. Nath, K. P. Bhargava and K. Shanker, Synthesis and antiparkinsonian activity of styryl quinazolones,(1982) 802-804.
  11. 11. F. Roubinek, J. Vavrina and Z. Budesinsky, 3-Aminoalkyl- and 3-benzyl-4(3H)-quinazolinones,.(1982) 630-635; DOI: 10.1135/cccc19820630.
  12. 12. G. Y. Zhixiong, R. K. Bakshi,M. Chen, S. P. Rohrer, S. D. Feighner, S. S. Pong, A. D. Howard, A. Blake, E. T. Birzin, L. Locco, R. M. Parmar, W. W. S. Chan, J. M. Schaeffer, R. G. Smith, A. A. Patchett and R. P. Nargaund, Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues,(2000) 5-8; DOI: 10.1016/S0960-894X(99)00584-3.
  13. 13. V. Alagarsamy, S. Murugesan, K. Dhanabal, M. Murugan and E. De Clercq, Anti-HIV, antibacterial and antifungal activities of some novel 2-methyl-3-(substituted methylamino)-(3)-quinazolin-4-ones,(2007) 304-307; DOI: 10.4103/0250-474X.33167.
  14. 14. S. K. Pandey, A. Singh, A. Singh and A. Nizamuddin, Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings,(2009) 1188-1197; DOI: 10.1016/j.ejmech.2008.05.033.
  15. 15. S. Jantova, R. Ovadekova, S. Letasiova, K. Spirkova and S. Stankovsky, Antimicrobial activity of some substituted triazoloquinazolines,(2005) 90-94; DOI: 10.1007/BF02931453.
  16. 16. M. S. Al-Said, M. M. Ghorab, M. S. Al-Dosari and M. M. Hamed, Synthesis andanticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety,(2011) 201-207; DOI: org/10.1016/j.ejmech.2010.11.002.
  17. 17. M. M. Ghorab, E. Noaman, M. M. F. Ismail, Y. A. Ammar, H. I. Heiba and M. Y. Sayed, Novel antitumor and radioprotective sulfonamides containing pyrrolo[2,3-]pyrimidines,(2006) 405-413; DOI: 10.1002/chin.200643177.
  18. 18. M. M. Ghorab, Z. H. Ismail, S. M. Abdel-Gawad and A. Abdel Aziem, Antimicrobial activity of amino acid, imidazole, and sulfonamide derivatives of pyrazolo[3,4-]pyrimidine,.(2004) 57-62; DOI: 10.1002/hc.10212.
  19. 19. Y. Genç, R. Özkanca and Y. Bekdemir, Antimicrobial activity of some sulfonamide derivatives on clinical isolates of(2008) 17-23; DOI: 10.1186/1476-0711-7-17.
  20. 20. M. S. Al-Said, M. S. Bashandy, S. I. Al-Qasoumi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives,(2011) 137-141; DOI: 10.1016/j.ejmech.2010.10.024.
  21. 21. S. Guccion, A. Raffaelli, G. V. Barretta, L. M. Scolaro, S. Pucci and F. Russo, Potential of alkyl orthoformates as alkylating agents of non-electron rich nitrogen heterocycles,(1995) 1149-1158; DOI: 10.1002/jhet.5570320409.
  22. 22. Y. Murti, A. K. Singh and D. Pathak, New 6-bromo-2-methyl-3-(substituted phenyl)-(3)-quinazolin-4-ones with antimicrobial and antiinflammatory activities,(2011) 333-337; DOI: 10.4103/0250-474X.93512.
  23. 23. Z. H. Chohan, M. H. Youssoufi, A. Jarranpour and T. B. Hadda, Identification of antibacterial and antifungal pharmacophore sites for potent bacteria and fungi inhibition: indolenyl sulfonamide derivatives,.(2010) 1189-1199; DOI: 10.1016/j.ejmech.2009.11.029.
  24. 24. G. Wolber and T. Langer, LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters,(2005) 160-169; DOI: 10.1021/ ci049885e.
  25. 25. S. Friederike, L. Sven, H. Thomas, S. Karsten, L. F. Philip and H. Hans-Dieter, Pharmacophore definition and three-dimensional quantitative structure-activity relationship study on structurally diverse prostacyclin receptor agonists,(2002) 1103-1111; DOI: 10.1124/ mol.62.5.1103.
  26. 26. S. John, S. Thangapandian, S. Sakkiah and K. W. Lee, Potent bace-1 inhibitor design using pharmacophore modeling,screening and molecular docking studies,(2011) S1-S28; DOI: 10.1186/1471-2105-12-S1-S28.
  27. 27. J. Garín, E. Meléndez, F. L. Merchán, P. Merino, J. Orduna, T. Tejero, Synthesis of unsymmetrical diheteroarylbenzenes: Benzoazole and quinazoline derivatives,.(1991) 359-363; DOI: 10.1002/jhet.5570280229.
  28. 28. I. Graefe, K. Kottke, H. Kuehmstedt and D. Knoke, Synthesis of 3-hetaryl-4-oxo-2-thioxo- and 3-heterotaryl-2,4-dioxo-1,2,3,4-tetrahydroquinazolines,(1990) 530-531;(1991); DOI: 10.1002/chin.199148179.
  29. 29. A. A. Fahmi, S. C. Mekki, H. A. Alber, A. S. Shawlai, H. N. Hassaneen and H. Abdelhamid, A Facile synthesis of some pyrazolo analogues of tricyclic purine derivative via hydrazonoyl halides,(1994) 140-149.
  30. 30. J. Fathi, V. Masand, R. Jawarkar, R. Mouhoub and T. Ben Hadda, POM as efficient tools to predict and improve both antibacterial and antifungal activity of aryl aldazines,.(2011) 57-68.
DOI: https://doi.org/10.2478/acph-2013-0006 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 1 - 18
Published on: Mar 12, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2013 Mostafa M. Ghorab, Zienab H. Ismail, Awwad A. Radwan, Mohamad Abdalla, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.